OverviewSuggest Edit

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. Avid provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

TypePublic
Founded1981
HQTustin, US
Websiteavidbio.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Apr 2019)211(+15%)
Job Openings14
Revenue (FY, 2020)$59.7 M(+12%)
Share Price (Oct 2020)$7.7 (-2%)
Cybersecurity ratingBMore

Key People/Management at Avid Bioservices

Joseph Carleone

Joseph Carleone

Chairman of the Board
Rick Hancock

Rick Hancock

Interim President & CEO
Mark R. Bamforth

Mark R. Bamforth

Director
Daniel Hart

Daniel Hart

Chief Financial Officer
Richard B. Hancock

Richard B. Hancock

Interim President and CEO
Mark Ziebell

Mark Ziebell

VP General Counsel & Corporate Secretary
Show more

Avid Bioservices Office Locations

Avid Bioservices has an office in Tustin
Tustin, US (HQ)
2642 Michelle Dr #200
Show all (1)

Avid Bioservices Financials and Metrics

Avid Bioservices Revenue

Avid Bioservices's revenue was reported to be $59.70 m in FY, 2020
USD

Revenue (Q1, 2021)

25.4m

Gross profit (Q1, 2021)

8.5m

Gross profit margin (Q1, 2021), %

33.6%

Net income (Q1, 2021)

4.7m

EBIT (Q1, 2021)

4.7m

Market capitalization (14-Oct-2020)

434.1m

Closing stock price (14-Oct-2020)

7.7

Cash (31-Jul-2020)

28.2m

EV

428.1m
Avid Bioservices's current market capitalization is $434.1 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

15.2m21.7m22.4m26.8m44.7m57.6m53.6m53.6m59.7m

Revenue growth, %

20%67%

Cost of goods sold

56.5m46.4m55.8m

Gross profit

(2.9m)7.2m3.9m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

5.7m4.2m3.3m4.3m6.1m7.0m4.7m7.4m3.9m5.5m6.3m5.7m9.7m9.5m6.7m5.6m23.4m10.7m12.6m10.2m13.8m15.3m18.3m13.6m25.4m

Cost of goods sold

11.4m9.8m11.7m14.2m15.0m12.8m16.8m

Gross profit

1.2m334.0k2.1m1.1m3.4m785.0k8.5m

Gross profit Margin, %

9%3%15%7%18%6%34%
USDQ1, 2012

Financial Leverage

2.3 x
Show all financial metrics

Avid Bioservices Operating Metrics

FY, 2016

Phase I/II Trials Products

1
Show all operating metrics

Avid Bioservices Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Avid Bioservices Revenue Breakdown

Embed Graph

Avid Bioservices revenue breakdown by business segment: 99.3% from Contract manufacturing services and 0.7% from Other

Avid Bioservices Online and Social Media Presence

Embed Graph

Avid Bioservices News and Updates

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments

-- Recorded First Quarter Revenue of $25.4 Million -- -- Signed Three New Customers and Project Expansion Orders with Current Customers for $20 Million --

Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments

-- Recorded Third Quarter Revenue of $13.6 Million -- -- Signed New Customer and Project Expansion Orders with Current Customers for $20 Million  --

Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments

-- Achieved First Quarter Revenue of $15.3 Million; Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 Million -- -- Signed Two Contract Manufacturing Agreements with New and Existing Customers --

Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments

 -- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146% Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 --

Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2019 and Recent Developments

-- Achieved Revenue of $13.8 Million, an Increase of 102%Compared to Prior Year Quarter -- -- Signed Project Expansion Orders with Existing Customers Representing $23.8 Million --

Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2019 and Recent Developments

-- F iscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Signed Project Expansion Orders for $6.3 Million with Current Customers --
Show more

Avid Bioservices Blogs

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments

-- Appointed Nicholas Green as President and Chief Executive Officer -- -- Recorded Fourth Quarter Revenue of $12.6 Million and Annual Revenue of $59.7 Million -- -- S igned $23 Million in Business Orders and A chieved Record Backlog of $65 Million  During the Fourth Quarter   -- -- Project Fiscal

Avid Bioservices Names Nicholas Green as President and Chief Executive Officer

Seasoned Executive Brings More than 30 Years of Pharmaceutical and Healthcare Services Industry Experience to Lead Avid Through Next Phase of Growth and Expansion TUSTIN, Calif. , June 23, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract

Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing

Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances TUSTIN, Calif. and MORGAN HILL, Calif. , May 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.

Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia

Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia Content Import Mon, 04/13/2020 - 08:05 Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility fo…

Avid Bioservices Receives Five 2020 CMO Leadership Awards

Company Honored for Capabilities, Expertise, Reliability, Compatibility, and Service in the Contract Development and Manufacturing Industry Named 2020 CMO Leadership Award Champion in Categories of Expertise and Service TUSTIN, Calif. , March 26, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020 Content Import Tue, 03/03/2020 - 16:05 Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020 …
Show more

Avid Bioservices Frequently Asked Questions

  • When was Avid Bioservices founded?

    Avid Bioservices was founded in 1981.

  • Who are Avid Bioservices key executives?

    Avid Bioservices's key executives are Joseph Carleone, Rick Hancock and Mark R. Bamforth.

  • How many employees does Avid Bioservices have?

    Avid Bioservices has 211 employees.

  • What is Avid Bioservices revenue?

    Latest Avid Bioservices annual revenue is $59.7 m.

  • What is Avid Bioservices revenue per employee?

    Latest Avid Bioservices revenue per employee is $282.9 k.

  • Who are Avid Bioservices competitors?

    Competitors of Avid Bioservices include Motif Bio, Recro Gainesville and Paion.

  • Where is Avid Bioservices headquarters?

    Avid Bioservices headquarters is located at 2642 Michelle Dr #200, Tustin.

  • Where are Avid Bioservices offices?

    Avid Bioservices has an office in Tustin.

  • How many offices does Avid Bioservices have?

    Avid Bioservices has 1 office.